hrcak mascot   Srce   HID

Acta Pharmaceutica, Vol. 63 No. 3, 2013.

Pregledni rad
https://doi.org/10.2478/acph-2013-0024

Nanofibers and their biomedical use

ROMANA ROŠIC ; University of Ljubljana, Faculty of Pharmacy, Department of Pharmaceutical Technology, 1000 Ljubljana, Slovenia
PETRA KOCBEK ; University of Ljubljana, Faculty of Pharmacy, Department of Pharmaceutical Technology, 1000 Ljubljana, Slovenia
JAN PELIPENKO ; University of Ljubljana, Faculty of Pharmacy, Department of Pharmaceutical Technology, 1000 Ljubljana, Slovenia
JULIJANA KRISTL ; University of Ljubljana, Faculty of Pharmacy, Department of Pharmaceutical Technology, 1000 Ljubljana, Slovenia
SAŠA BAUMGARTNER ; University of Ljubljana, Faculty of Pharmacy, Department of Pharmaceutical Technology, 1000 Ljubljana, Slovenia

Puni tekst: engleski, pdf (639 KB) str. 295-304 preuzimanja: 668* citiraj
APA 6th Edition
ROŠIC, R., KOCBEK, P., PELIPENKO, J., KRISTL, J. i BAUMGARTNER, S. (2013). Nanofibers and their biomedical use. Acta Pharmaceutica, 63 (3), 295-304. https://doi.org/10.2478/acph-2013-0024
MLA 8th Edition
ROŠIC, ROMANA, et al. "Nanofibers and their biomedical use." Acta Pharmaceutica, vol. 63, br. 3, 2013, str. 295-304. https://doi.org/10.2478/acph-2013-0024. Citirano 23.02.2019.
Chicago 17th Edition
ROŠIC, ROMANA, PETRA KOCBEK, JAN PELIPENKO, JULIJANA KRISTL i SAŠA BAUMGARTNER. "Nanofibers and their biomedical use." Acta Pharmaceutica 63, br. 3 (2013): 295-304. https://doi.org/10.2478/acph-2013-0024
Harvard
ROŠIC, R., et al. (2013). 'Nanofibers and their biomedical use', Acta Pharmaceutica, 63(3), str. 295-304. doi: https://doi.org/10.2478/acph-2013-0024
Vancouver
ROŠIC R, KOCBEK P, PELIPENKO J, KRISTL J, BAUMGARTNER S. Nanofibers and their biomedical use. Acta Pharm. [Internet]. 2013 [pristupljeno 23.02.2019.];63(3):295-304. doi: https://doi.org/10.2478/acph-2013-0024
IEEE
R. ROŠIC, P. KOCBEK, J. PELIPENKO, J. KRISTL i S. BAUMGARTNER, "Nanofibers and their biomedical use", Acta Pharmaceutica, vol.63, br. 3, str. 295-304, 2013. [Online]. doi: https://doi.org/10.2478/acph-2013-0024

Sažetak
The idea of creating replacement for damaged or diseased tissue, which will mimic the physiological conditions and simultaneously promote regeneration by patients' own cells, has been a major challenge in the biomedicine for more than a decade. Therefore, nanofibers are a promising solution to address these challenges. These are solid polymer fibers with nanosized diameter, which show improved properties compared to the materials of larger dimensions or forms and therefore cause different biological responses. On the nanometric level, nanofibers provide a biomimetic environment, on the micrometric scale three-dimensional architecture with the desired surface properties regarding the intended application within the body, while on the macrometric scale mechanical strength and physiological acceptability. In the review, the development of nanofibers as tissue scaffolds, modern wound dressings for chronic wound therapy and drug delivery systems is highlighted. Research substantiates the effectiveness of nanofibers for enhanced tissue regeneration, but ascertains that evidences from clinical studies are currently lacking. Nevertheless, due to the development of nano- and bio-sciences, products on the market can be expected in the near future.

Ključne riječi
nanofibers; tissue engineering; wound dressings; drug delivery systems; analogues of ECM

Hrčak ID: 102050

URI
https://hrcak.srce.hr/102050

Posjeta: 826 *